James Douglas explains how COVID-19 has been a significant catalyst for positive change for the healthcare sector, driving efficiencies through the system. This is yielding compelling investment opportunities – particularly in life sciences tools & services. But what are the implications of the US Presidential election for healthcare and what is the outlook for 2021?
James Douglas, PhD
James joined Polar Capital in September 2015 and is a Fund Manager for the Healthcare team. He was appointed Co-Fund Manager for the Polar Capital Global Healthcare Trust in May 2017.
Prior to joining Polar Capital, James worked in equity sales specialising in global healthcare at Morgan Stanley, RBS and HSBC. James also has equity research experience garnered from his time at UBS, where he worked as an analyst in the European pharmaceutical and biotechnology team. Before moving across to the financial sector, he worked as a consultant for EvaluatePharma.